Slide 1: A Transformation in Medical CT
For personal use only A TRANSFORMATION IN MEDICAL CT Applying NEX Technology to Expand Access to Advanced Medical Imaging 3 August 2026
Slide 2: Important Notice
IMPORTANT NOTICE THIS PRESENTATION HAS BEEN APPROVED BY THE BOARD OF MICRO-X LIMITED S C O P E & L I M I T A T I O N S This Presentation has been prepared by Micro-X Limited (Micro-X or the Company) (ASX:MX1). The Presentation is a summary only which is current only as at the date of this Presentati
Slide 3: Important Notice - Continued
IMPORTANT NOTICE - CONTINUED N O T I N V E S T M E N T A D V I C E The information contained in this Presentation is not financial product, investment, legal, taxation or other advice or any recommendation to acquire securities in the Company. No reliance may be placed for any purpose whatsoever on
Slide 4: Company Overview: A Vision to Transform Medical Imaging
COMPANY OVERVIEW A Vision to Transform Medical Imaging ABOUT MICRO-X PURPOSE ➢ An Australian listed company (ASX:MX1) Creating revolutionary X-ray imaging to better lives commercialising innovative X-ray and CT imaging solutions for global healthcare ➢ First to commercialise carbon nanotube cold cat
Slide 5: Micro-X Strategic Reset
MICRO-X STRATEGIC RESET Strategic reset being implemented from the beginning of FY27 under new leadership New Leadership 1 Brian Gonzales, PhD, Chief Scientific Officer and CEO US, elevated to CEO of the Group Kingsley Hall steps down as CEO on 3 August 2026, remaining in an advisory capacity to sup
Slide 6: New Leadership
NEW LEADERSHIP Driving innovation and delivering commercial impact 21+ years at Forefront of CNT X-ray Technology 2005+ PhD research on advanced CT imaging algorithms combined with CNT X-ray technology at the University of North Carolina Joined Micro-X and Drove NEX Technology and CT Development 201
Slide 7: Focus on Medical CT
FOCUS ON MEDICAL CT Micro-X vision to bring advanced CT imaging wherever a patient requires care Conventional Medical CT Micro-X Accessible CT For personal use only Core Benefits Same Benefits ➢ Diagnostic accuracy – high-resolution 3D imaging of bones, blood ➢ Same diagnostic accuracy – powered by
Slide 8: Micro-X Leadership Team
MICRO-X LEADERSHIP TEAM Experienced Leadership with Deep Knowledge of the Business For personal use only Brian Gonzales Anthony Skeats Peter Dickman Bree Farrugia Shixin Sun CEO COO CFO General Counsel Head of Sales Alex Blackburn Chris Delnooz Tiffany House Daniel Pini Jolanta Ganczarczky Head of C
Slide 9: Why Micro-X
WHY MICRO-X An established CNT X-ray business, now focused on medical CT Proprietary, Proven Technology 1 World-first cold-cathode (carbon nanotube) X-ray platform, smaller, lighter and more precise than conventional systems Extensive, market-leading IP and years of development that competitors can
Slide 10: $8M Note Commitments – Use of Proceeds
$8M NOTE COMMITMENTS – USE OF PROCEEDS Funding Head CT validation, commercial readiness and Rover scale-up USE OF PROCEEDS % OF NOTE PROCEEDS (INDICATIVE) KEY ASSUMPTIONS What the note proceeds fund R&D – Head CT development ~25% ➢ Continued R&D investment, primarily Head CT development ➢ Head CT co
Slide 11: Appendix: Additional Detail About the Company and Markets
APPENDIX ADDITIONAL DETAIL ABOUT THE COMPANY AND MARKETS For personal use only Supporting information on our technology, products, markets, strategy and financial discipline TECHNOLOGY PRODUCTS MARKETS STRATEGY & FINANCIALS Our NEX platform and capabilities Rover, Head CT, Full Body CT, Large, growi
Slide 12: Micro-X's NEX Technology
MICRO-X'S NEX TECHNOLOGY A Fundamental Change in the Basic X-ray Technology Used in Medical Imaging Conventional X-ray NEX Tube BULKY · INEFFICIENT COMPACT · EFFICIENT Hot filament tube Cold cathode CNT tube Heated wire sheds electrons, like an incandescent bulb An electric field releases electrons
Slide 13: What Micro-X Makes
WHAT MICRO-X MAKES Medical Imaging Products and Security Imaging Funded Development For personal use only ROVER MEDICAL CT AIRPORT SECURITY SCREENING A lightweight, mobile X-ray unit Compact, portable CT scanners A miniaturised baggage CT scanner integrated into a small checkpoint booth First Produc
Slide 14: Increasing Global Need
INCREASING GLOBAL NEED Growing demand for equitable access to advanced medical imaging EMERGING RURAL & REGIONAL CONVENTIONAL EMERGENCY ECONOMIES COMMUNITIES HOSPITALS PATIENTS want to upgrade their want the same level of struggle to keep up with need immediate healthcare systems care as metro areas
Slide 15: The Market Opportunity
THE MARKET OPPORTUNITY Significant Market Increase Beyond Conventional CT Imaging – Starting with Stroke Imaging Conventional CT – in hospital imaging suites, where the market is focused today 2026 Market Size1: $11.9B | CAGR: 6.5% New & Growing Markets that Need Advanced Imaging For personal use on
Slide 16: A Transformation Is Required
A TRANSFORMATION IS REQUIRED Conventional imaging was designed using 100-year-old technology PAST: SAME SYSTEMS, LIMITED BY 100-YEAR-OLD TECHNOLOGY FUTURE: REAL TRANSFORMATION For personal use only Focused on Innovation limited Investment Different brands. incremental to small workflow focused on to
Slide 17: CT Market Landscape
CT MARKET LANDSCAPE Incumbents dominate conventional CT; Micro-X is developing significantly lighter diagnostic systems Conventional CT1 Accessible Diagnostic CT2 Major Vendors Market Share Target system weight compared with existing diagnostic CT platforms Micro-X 70 kg Head CT target 5% 6% For per
Slide 18: Micro-X Technology Transformation
MICRO-X TECHNOLOGY TRANSFORMATION Transforming Medical Imaging by Addressing the Limits of Conventional Imaging Technology ACCESSIBILITY LIMITED BY 100- NEX TECHNOLOGY ADDRESSES YEAR-OLD TECHNOLOGY THESE LIMITS Complexity, Size, and Compact and Weight of Systems Lightweight Systems For personal use
Slide 19: NEX Technology Platform
NEX TECHNOLOGY PLATFORM A Technology Platform to Maximise Benefits of NEX Tubes MICRO-X’S NANO-ELECTRONIC X-RAY (NEX) TECHNOLOGY PLATFORM SMALLER & SOLID-STATE GENERATORS MULTI-TUBE ARRAYS ALGORITHMS & SOFTWARE SIMPLER X-RAY TUBES For personal use only World first electronic X-ray Solid-state high-v
Slide 20: Validation & Partnerships
VALIDATION & PARTNERSHIPS Non-dilutive funding de-risks our technology development and unlocks value All funding amounts in A$ Up to $31.7M funding Up to $25M funding $8M funding $4.4M funding DEVELOPMENT PARTNERS Checkpoints & Baggage Full Body CT Head CT Head CT For personal use only Scanner – U.S
Slide 21: Refined Strategic Focus
REFINED STRATEGIC FOCUS Setting up Micro-X to grow into a market-leading medical CT company PAST NEW FOCUS Multiple Projects Building NEX platform, but also For personal use only distractions & dead-ends Focus on Medical CT Narrowed development priorities to deliver on major market opportunities Fun
Slide 22: Focus on Medical Imaging Products
FOCUS ON MEDICAL IMAGING PRODUCTS A Plan to Make High-end Medical Imaging that is Significantly More Accessible CURRENT PRODUCT NEXT PRODUCT FUTURE PRODUCT For personal use only MICRO-X ROVER MICRO-X HEAD CT FULL BODY CT FDA-cleared & CE MDR certified Currently in clinical trials In development, fun
Slide 23: Medical CT – Development Priorities
MEDICAL CT – DEVELOPMENT PRIORITIES Refined development priorities PLAN Transition from Funded Development, advancing multiple projects, to a narrowed focus on medical CT applications where Micro-X NEX technology advantages can be turned into commercially differentiated products KEY FOCUS & OBJECTIV
Slide 24: Regulatory & Reimbursement Pathway
REGULATORY & REIMBURSEMENT PATHWAY Head CT: pathway from clinical trials to commercial launch across Australia and the United States 01 CLINICAL VALIDATION 02 REGULATORY PATHWAY ✓ Done Two imaging test benches completed for ASA sites ✓ Done FDA 510(k) clearance pathway confirmed with FDA For persona
Slide 25: Strategic Sales
STRATEGIC SALES Scalable and efficient market execution PLAN Transition from an unstructured Rover sales effort to a strategic approach Informed by a 10-week review from revenue growth consultancy Altus Alliance KEY FOCUS & OBJECTIVES OPPORTUNITIES For personal use only 1 Restructure sales team, rev
Slide 26: Financial Discipline
FINANCIAL DISCIPLINE An integrated plan to prioritise core Head CT and extend runway New CFO, Peter Dickman, from end of March 2026 IDENTIFIED ANNUALISED SAVINGS 1 ➢ Stronger business partnering, financial rigour and clearer Board reporting $3M+ p.a. being implemented Rigorous cost discipline ➢ Econ
Slide 27: General Glossary of Terms
GENERAL GLOSSARY OF TERMS ARPA-H Advanced Research Projects Agency for Health (USA) ER Emergency room / emergency department ASA Australian Stroke Alliance FDA 510(k) US medical device clearance pathway ASIC Australian Securities & Investments Commission (Australia) FY27 Financial year ending 30 Jun